These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains. da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria. Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398 [TBL] [Abstract][Full Text] [Related]
8. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity. Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents. Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents. Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis. Castagnolo D; Radi M; Dessì F; Manetti F; Saddi M; Meleddu R; De Logu A; Botta M Bioorg Med Chem Lett; 2009 Apr; 19(8):2203-5. PubMed ID: 19299129 [TBL] [Abstract][Full Text] [Related]
12. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates. Foroumadi A; Soltani F Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitubercular screening of [(2-chloroquinolin-3-yl)methyl] thiocarbamide derivatives. Kumar S; Upmanyu N; Afzal O; Bawa S Chem Biol Drug Des; 2014 Nov; 84(5):522-30. PubMed ID: 24750991 [TBL] [Abstract][Full Text] [Related]
14. Oxazolidinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis. Ashtekar DR; Costa-Periera R; Shrinivasan T; Iyyer R; Vishvanathan N; Rittel W Diagn Microbiol Infect Dis; 1991; 14(6):465-71. PubMed ID: 1802533 [TBL] [Abstract][Full Text] [Related]
15. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action. Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902 [TBL] [Abstract][Full Text] [Related]